Unlock Critical Insights in Advanced Therapies with Our Expert Reports

Explore our comprehensive IP landscape and GMP hPSC start material vendor analysis reports

PROUD SPONSOR

Time-limited offer, ending 31/12 2024

Values for Decision Makers -

Values for Decision Makers -

In a rapidly evolving field of advanced therapies, making informed decisions is crucial for maintaining a competitive edge. Our reports provide decision-makers with the strategic intelligence needed to navigate complex landscapes, from intellectual property to GMP-compliant start material providers.

EXPERT REPORTS

Vendor assessment of GMP hPSC start material providers

In the fast-growing field of PSC-derived cell therapies, choosing the right starting materials is critical to success. Our comprehensive evaluation of GMP hPSC lines offers a clear path forward, providing actionable insights into derivation technologies, IP, donor eligibility, and regulatory standards. With over 26 hiPSC lines analyzed, this report highlights the best options for clinical and commercial development. It is designed to help you avoid costly mistakes and accelerate the development of innovative hPSC-based therapies.

Global iPSC Patent Landscape Analysis

This patent landscape analysis offers a comprehensive overview of the technological trends in iPSC production, focusing on reprogramming factors, delivery methods, and source cell types. It provides key insights for making informed strategic decisions in the competitive field of iPSC technology. The report identifies leading players and maps the patent environment, helping businesses understand the state of the art and plan their next steps in this rapidly evolving sector.

KEY VALUES

Strategic Insight

Gain a deep understanding of the IP landscape and vendor ecosystem to identify opportunities, avoid pitfalls, and make data-driven decisions that align with your company’s strategic goals.

Risk Mitigation

Our analyses help de-risk your projects by identifying potential IP conflicts, regulatory challenges, and supplier vulnerabilities, allowing you to proactively address these issues.

Optimized Vendor Selection

Make better choices by accessing comprehensive evaluations of GMP hPSC start material providers, ensuring your supply chain is robust, compliant, and scalable.

BENEFITS

Accelerated Development

Reduce time to market by leveraging insights that streamline decision-making and optimize operational strategies.

Time/Cost Efficiency

Identify cost-saving opportunities through vendor comparisons and IP strategies that prevent unnecessary litigation or delays. Further, save time by having us do the vendor outreach and due dilligence.

Enhanced Compliance

Stay ahead of regulatory changes and ensure your processes align with industry standards, supporting smoother approvals.

By integrating our expert-driven reports into your decision-making process, you can confidently advance your projects, secure your market position, and maximize your progress.

What Clients Are Saying

"The IP Landscape Analysis from HOYA Consulting gave us critical insights into the Advanced Therapy space. It helped us navigate potential IP risks and identify opportunities. The report made a complex process much more manageable, and the team was a pleasure to work with.”

Stephanie Mattsson, CCRM Nordic
Director, Venture Development

Meet the authors

Heather Main - Cofounder and Principal Consultant

Ajdin Jakupovic - Cofounder and Managing Partner

Anna Falk - Cofounder and Subject Matter Expert

Get in touch.

Have questions about our reports or want to explore how our insights can support your projects? Or are you still not convinced and want a teaser? No matter, we’d love to hear from you! Fill out the form below, and our team will get back to you promptly. Let’s connect and discuss how we can drive your advanced therapy development forward.

HOYA - ABOUT

HOYA - ABOUT

HOYA is your strategic partner in advanced therapy, with deep expertise in pluripotent-derived cell therapies. We help our clients de-risk complex preclinical and commercial challenges, accelerating early research to broad patient access. Leveraging our extensive global network and tailoring solutions to each client’s unique needs, we help drive innovation forward.

Our Services

  • With deep knowledge of hPSC, we offer the hands-on technical expertise needed to advance your research from lab to clinic, ensuring the highest quality and compliance throughout the process.

  • We provide a roadmap for GMP compliance, ensuring your cell therapy products are manufactured with the highest standards of quality.

  • Our strong relationships with leading academic institutions, biotech companies, and industry regulators give you access to a powerful network that can accelerate the development of your therapies.

Advanced Therapy Translation

  • From concept to clinical trials, we guide the entire product development process for hPSC-derived therapies, focusing on the regulatory, technical, and commercial aspects. Our team is well-versed in overcoming the hurdles of product validation and GMP operations.

  • We connect academia with industry leaders to foster collaborations that push the boundaries of cell therapy innovation. By leveraging our extensive network of industrial partners, we help accelerate research into practical, market-ready solutions.

  • Navigating the transition from research to GMP manufacturing can be challenging. We provide pre-GMP support to ensure your processes, materials, and protocols are aligned with regulatory expectations, minimizing delays and ensuring smooth progression to full-scale production.

Research and Development

Finance and Growth

  • Stay ahead of the competition with our in-depth market analysis. We provide actionable insights into emerging trends, competitor activities, and market demands within the cell therapy landscape, empowering you to make informed business decisions.

  • Whether you're at the initial stages of development or looking to commercialize, we offer strategic guidance tailored to your specific needs. Our expertise covers regulatory pathways, product lifecycle management, and commercialization strategies to ensure your cell therapies succeed.

  • We help you identify and secure grant funding to propel your cell therapy projects forward. Our knowledge of funding programs and the right partners will assist in writing and submitting grants in a timely and efficient manner.